Concepedia

Rebecca Soska

RS

Statistics

Publications

8

Citations

679

H-Index

8

Active since

2009

Affiliations

Amicus Therapeutics (United States)(Current)

University of Cape Town

Rebecca Soska is an author at Amicus Therapeutics (United States) specializing in biochemistry, enzymology, and life sciences.

Publications per year

2009–2019

8

Publications

8

The pharmacological chaperone isofagomine increases the activity of the Gaucher disease L444P mutant form of <b>β</b>‐glucosidase

Richie Khanna, Elfrida R. Benjamin, Lee Pellegrino et al. · FEBS Journal · 2010 · 158 citations · Full text

, , +16

The Pharmacological Chaperone 1-Deoxygalactonojirimycin Reduces Tissue Globotriaosylceramide Levels in a Mouse Model of Fabry Disease

Richie Khanna, Rebecca Soska, Yi Lun et al. · Molecular Therapy · 2009 · 140 citations · Full text

, , +16

Co-administration With the Pharmacological Chaperone AT1001 Increases Recombinant Human α-Galactosidase A Tissue Uptake and Improves Substrate Reduction in Fabry Mice

Elfrida R. Benjamin, Richie Khanna, Adriane Schilling et al. · Molecular Therapy · 2012 · 93 citations · Full text

, , +15

The Pharmacological Chaperone AT2220 Increases Recombinant Human Acid α-Glucosidase Uptake and Glycogen Reduction in a Mouse Model of Pompe Disease

Richie Khanna, John J. Flanagan, Jessie Feng et al. · PLoS ONE · 2012 · 83 citations · Full text

, , +17

Improved efficacy of a next-generation ERT in murine Pompe disease

Su Xu, Yi Lun, Michelle Frascella et al. · JCI Insight · 2019 · 82 citations · Full text

, , +17

1–5 of 8